Role of T3 in Management of Hypothyroidism
Indian Journal of Endocrinology and Metabolism · 2025-07 · 29 (4) · 402-407
DOI: 10.4103/ijem.ijem_294_24 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Indian Journal of Endocrinology and Metabolism, online erschienen am 26.08.2025. Verfasst von Sanjay Kalra und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Bharti Hospital, Karnal, Haryana, India. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
The management of hypothyroidism is based on the assumption that levothyroxine monotherapy normalizes thyroid hormone homeostasis, rendering patients clinically and biochemically euthyroid. However, a subset of patients treated with levothyroxine (LT4) are dissatisfied as they continue to have symptoms such as fatigue, weight gain, and difficulty in concentration. Some patients do not achieve normalization of thyroid-stimulating hormone despite adherence to adequate LT4 dosing. It has been proposed that liothyronine (LT3) may benefit such patients. This review addresses the specific role of LT3 in the management of hypothyroidism with an emphasis on practical considerations and a focus on appropriate patient selection. It identifies clinical challenges where patient outcomes are improved by adding LT3 to LT4 therapy, including myxedema coma, preoperative management, and situations where swift resolution of hypothyroidism is warranted. Further, it addresses the challenges faced in dose titration of LT4 and LT3 and the importance of monitoring therapy with LT3.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology, Bharti Hospital, Karnal, Haryana, India.
- Institute of Endocrinology and Diabetes, Max Healthcare, Saket, India.
- Apollo Centre of Obesity, Diabetes and Endocrinology, Indraprastha Apollo Hospital, New Delhi, India.
- Consultant Endocrinologist, Chennai Diabetes and Endocrine Clinic, Chennai, Tamil Nadu, India.
- Department of Endocrinology and Diabetes, Bangalore Endocrinology and Diabetes Research Centre, Bengaluru, Karnataka, India.
Zitieren
APA
Kalra, S., Mithal, A., Wangnoo, S. K., Seshadri, K., & Dharmalingnam, M. (2025). Role of T3 in Management of Hypothyroidism. Indian Journal of Endocrinology and Metabolism, 29(4), 402-407. https://doi.org/10.4103/ijem.ijem_294_24
Vancouver
Kalra S, Mithal A, Wangnoo SK, Seshadri K, Dharmalingnam M. Role of T3 in Management of Hypothyroidism. Indian Journal of Endocrinology and Metabolism. 2025;29(4):402-407. doi:10.4103/ijem.ijem_294_24
BibTeX
@article{Kalra2025,
author = {Kalra, Sanjay and Mithal, Ambrish and Wangnoo, Subhash K and Seshadri, Krishna and Dharmalingnam, Mala},
title = {Role of T3 in Management of Hypothyroidism},
journal = {Indian Journal of Endocrinology and Metabolism},
year = {2025},
volume = {29},
number = {4},
pages = {402--407},
doi = {10.4103/ijem.ijem_294_24}
}
EUVIMED